{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:59:43Z","timestamp":1793851183087,"version":"4.6.1"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872412"],"award-info":[{"award-number":["81872412"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602303"],"award-info":[{"award-number":["81602303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31700736"],"award-info":[{"award-number":["31700736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771273"],"award-info":[{"award-number":["31771273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As crucial antigen presenting cells, dendritic cells (DCs) play a vital role in tumor immunotherapy. Taking into account the many recent advances in DC biology, we discuss how DCs (1) recognize pathogenic antigens with pattern recognition receptors through specific phagocytosis and through non-specific micropinocytosis, (2) process antigens into small peptides with proper sizes and sequences, and (3) present MHC-peptides to CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells to initiate immune responses against invading microbes and aberrant host cells. During anti-tumor immune responses, DC-derived exosomes were discovered to participate in antigen presentation. T cell microvillar dynamics and TCR conformational changes were demonstrated upon DC antigen presentation. Caspase-11-driven hyperactive DCs were recently reported to convert effectors into memory T cells. DCs were also reported to crosstalk with NK cells. Additionally, DCs are the most important sentinel cells for immune surveillance in the tumor microenvironment. Alongside DC biology, we review the latest developments for DC-based tumor immunotherapy in preclinical studies and clinical trials. Personalized DC vaccine-induced T cell immunity, which targets tumor-specific antigens, has been demonstrated to be a promising form of tumor immunotherapy in patients with melanoma. Importantly, allogeneic-IgG-loaded and HLA-restricted neoantigen DC vaccines were discovered to have robust anti-tumor effects in mice. Our comprehensive review of DC biology and its role in tumor immunotherapy aids in the understanding of DCs as the mentors of T cells and as novel tumor immunotherapy cells with immense potential.<\/jats:p>","DOI":"10.1186\/s13045-020-00939-6","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:02:04Z","timestamp":1598878924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":435,"title":["Dendritic cell biology and its role in tumor immunotherapy"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-7872","authenticated-orcid":false,"given":"Yingying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria W.","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ning","family":"Lyv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Zhong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"issue":"4","key":"939_CR1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/pr.114.009456","volume":"67","author":"S Anguille","year":"2015","unstructured":"Anguille S, Smits E, Bryant C, Van Acker H, Goossens H, Lion E, et al. Dendritic cells as pharmacological tools for cancer immunotherapy. Pharmacol Rev. 2015;67(4):731\u201353.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"939_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-018-0637-x","volume":"11","author":"P Fang","year":"2018","unstructured":"Fang P, Li X, Dai J, Cole L, Camacho JA, Zhang Y, et al. Immune cell subset differentiation and tissue inflammation. J Hematol Oncol. 2018;11(1):97.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"939_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nri.2016.115","volume":"16","author":"Y Bordon","year":"2016","unstructured":"Bordon Y. Dendritic cells: sorting, sorted! Nat Rev Immunol. 2016;16(11):657.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"939_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/14760584.2014.957684","volume":"14","author":"D Benteyn","year":"2015","unstructured":"Benteyn D, Heirman C, Bonehill A, Thielemans K, Breckpot K. mRNA-based dendritic cell vaccines. Expert Rev Vaccines. 2015;14(2):161\u201376.","journal-title":"Expert Rev Vaccines"},{"key":"939_CR5","doi-asserted-by":"crossref","unstructured":"Leone DA, Rees AJ, Kain R. Dendritic cells and routing cargo into exosomes. Immunol Cell Biol. 2018.","DOI":"10.1111\/imcb.12170"},{"issue":"7","key":"939_CR6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.celrep.2016.01.048","volume":"14","author":"E Russo","year":"2016","unstructured":"Russo E, Teijeira A, Vaahtomeri K, Willrodt AH, Bloch JS, Nitschke M, et al. Intralymphatic CCL21 promotes tissue egress of dendritic cells through afferent lymphatic vessels. Cell Rep. 2016;14(7):1723\u201334.","journal-title":"Cell Rep"},{"issue":"1","key":"939_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nri3771","volume":"15","author":"EJ Pearce","year":"2015","unstructured":"Pearce EJ. Everts B: dendritic cell metabolism. Nat Rev Immunol. 2015;15(1):18\u201329.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"939_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.2795","volume":"15","author":"B Vander Lugt","year":"2014","unstructured":"Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol. 2014;15(2):161\u20137.","journal-title":"Nat Immunol"},{"issue":"5","key":"939_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nmat4848","volume":"16","author":"C Malinverno","year":"2017","unstructured":"Malinverno C, Corallino S, Giavazzi F, Bergert M, Li Q, Leoni M, Disanza A, et al. Endocytic reawakening of motility in jammed epithelia. Nat Mater. 2017;16(5):587\u201396.","journal-title":"Nat Mater"},{"issue":"10","key":"939_CR10","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood-2011-08-373944","volume":"119","author":"G Schreibelt","year":"2012","unstructured":"Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-) presentation by human blood BDCA3+ myeloid dendritic cells. Blood. 2012;119(10):2284\u201392.","journal-title":"Blood"},{"issue":"10","key":"939_CR11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015;21(10):1209\u201315.","journal-title":"Nat Med"},{"issue":"7696","key":"939_CR12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature25974","volume":"555","author":"MHT Stappers","year":"2018","unstructured":"Stappers MHT, Clark AE, Aimanianda V, Bidula S, Reid DM, Asamaphan P, et al. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus. Nature. 2018;555(7696):382\u20136.","journal-title":"Nature"},{"issue":"3","key":"939_CR13","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.18632\/oncotarget.2757","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang C, Zhou Q, Wang X, Wu X, Chen X, Li J, et al. The TLR7 agonist induces tumor regression both by promoting CD4(+)T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells. Oncotarget. 2015;6(3):1779\u201389.","journal-title":"Oncotarget"},{"issue":"1","key":"939_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41467-017-00356-3","volume":"8","author":"ST Chen","year":"2017","unstructured":"Chen ST, Li FJ, Hsu TY, Liang SM, Yeh YC, Liao WY, et al. CLEC5A is a critical receptor in innate immunity against Listeria infection. Nat Commun. 2017;8(1):299.","journal-title":"Nat Commun"},{"issue":"2","key":"939_CR15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pro.3083","volume":"26","author":"A Dos Santos","year":"2017","unstructured":"Dos Santos A, Hadjivasiliou A, Ossa F, Lim NK, Turgut A, Taylor ME, et al. Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences. Protein Sci. 2017;26(2):306\u201316.","journal-title":"Protein Sci"},{"issue":"30","key":"939_CR16","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.1820165116","volume":"116","author":"CM Jarvis","year":"2019","unstructured":"Jarvis CM, Zwick DB, Grim JC, Alam MM, Prost LR, Gardiner JC, et al. Antigen structure affects cellular routing through DC-SIGN. Proc Natl Acad Sci U S A. 2019;116(30):14862\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"939_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cancers11030418","volume":"11","author":"MK Hossain","year":"2019","unstructured":"Hossain MK, Wall KA. Use of dendritic cell receptors as targets for enhancing anti-cancer immune responses. Cancers (Basel). 2019;11:3.","journal-title":"Cancers (Basel)"},{"key":"939_CR18","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/ncomms4898","volume":"5","author":"SI Gringhuis","year":"2014","unstructured":"Gringhuis SI, Kaptein TM, Wevers BA, Mesman AW, Geijtenbeek TB. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKepsilon- and CYLD-dependent Bcl3 activation. Nat Commun. 2014;5:3898.","journal-title":"Nat Commun"},{"key":"939_CR19","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/ncomms6074","volume":"5","author":"SI Gringhuis","year":"2014","unstructured":"Gringhuis SI, Kaptein TM, Wevers BA, van der Vlist M, Klaver EJ, van Die I, et al. Fucose-based PAMPs prime dendritic cells for follicular T helper cell polarization via DC-SIGN-dependent IL-27 production. Nat Commun. 2014;5:5074.","journal-title":"Nat Commun"},{"issue":"1","key":"939_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.18632\/oncotarget.2700","volume":"6","author":"PZ Chao","year":"2015","unstructured":"Chao PZ, Hsieh MS, Cheng CW, Hsu TJ, Lin YT, Lai CH, et al. Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN. Oncotarget. 2015;6(1):159\u201370.","journal-title":"Oncotarget"},{"issue":"2","key":"939_CR21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.116.302795","volume":"116","author":"K Tanigaki","year":"2015","unstructured":"Tanigaki K, Sundgren N, Khera A, Vongpatanasin W, Mineo C, Shaul PW. Fcgamma receptors and ligands and cardiovascular disease. Circ Res. 2015;116(2):368\u201384.","journal-title":"Circ Res"},{"key":"939_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2017.06.012","volume":"85","author":"K Chen","year":"2017","unstructured":"Chen K, Bao Z, Gong W, Tang P, Yoshimura T, Wang J. Regulation of inflammation by members of the formyl-peptide receptor family. J Autoimmun. 2017;85:64\u201377.","journal-title":"J Autoimmun"},{"key":"939_CR23","first-page":"3","volume":"22","author":"H He","year":"2017","unstructured":"He H, Ye R. The formyl peptide receptors: diversity of ligands and mechanism for recognition. Molecules. 2017;22:3.","journal-title":"Molecules"},{"key":"939_CR24","doi-asserted-by":"crossref","unstructured":"Prevete N, de Paulis A, Sgambato D, Melillo R, D'Argenio G, Romano L, et al. Role of formyl peptide receptors in gastrointestinal healing. Curr Pharm Des 2018.","DOI":"10.2174\/1381612824666180516102234"},{"issue":"14","key":"939_CR25","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.bmc.2015.03.062","volume":"23","author":"TM Stepniewski","year":"2015","unstructured":"Stepniewski TM, Filipek S. Non-peptide ligand binding to the formyl peptide receptor FPR2--a comparison to peptide ligand binding modes. Bioorg Med Chem. 2015;23(14):4072\u201381.","journal-title":"Bioorg Med Chem"},{"key":"939_CR26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2017.11.030","volume":"143","author":"AM Yousif","year":"2018","unstructured":"Yousif AM, Ingangi V, Merlino F, Brancaccio D, Minopoli M, Bellavita R, et al. Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration. Eur J Med Chem. 2018;143:348\u201360.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"939_CR27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2016.05.076","volume":"166","author":"AJ Wolf","year":"2016","unstructured":"Wolf AJ, Reyes CN, Liang W, Becker C, Shimada K, Wheeler ML, et al. Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell. 2016;166(3):624\u201336.","journal-title":"Cell"},{"issue":"1","key":"939_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","volume":"101","author":"SH Yeon","year":"2017","unstructured":"Yeon SH, Yang G, Lee HE, Lee JY. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages. J Leukoc Biol. 2017;101(1):205\u201315.","journal-title":"J Leukoc Biol"},{"key":"939_CR29","doi-asserted-by":"crossref","unstructured":"Feng S, Fox D, Man SM: Mechanisms of gasdermin family members in inflammasome signaling and cell death. J Mol Biol 2018, 430(18 Pt B):3068-3080.","DOI":"10.1016\/j.jmb.2018.07.002"},{"issue":"1","key":"939_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12967-018-1394-x","volume":"16","author":"J Proff","year":"2018","unstructured":"Proff J, Brey CU, Ensser A, Holter W, Lehner M. Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains. J Transl Med. 2018;16(1):26.","journal-title":"J Transl Med"},{"issue":"5","key":"939_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jlb.49.5.511","volume":"49","author":"JG van de Winkel","year":"1991","unstructured":"van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol. 1991;49(5):511\u201324.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"939_CR32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/19420862.2018.1424611","volume":"10","author":"D Zhang","year":"2018","unstructured":"Zhang D, Whitaker B, Derebe MG, Chiu ML. FcgammaRII-binding centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibody. MAbs. 2018;10(3):463\u201375.","journal-title":"MAbs"},{"issue":"1","key":"939_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/imr.12331","volume":"268","author":"N Stapleton","year":"2015","unstructured":"Stapleton N, Einarsd\u00f3ttir H, Stemerding A, Vidarsson G. The multiple facets of FcRn in immunity. Immunol Rev. 2015;268(1):253\u201368.","journal-title":"Immunol Rev"},{"key":"939_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-immunol-041015-055420","volume":"34","author":"ER Unanue","year":"2016","unstructured":"Unanue ER, Turk V, Neefjes J. Variations in MHC class II antigen processing and presentation in health and disease. Annu Rev Immunol. 2016;34:265\u201397.","journal-title":"Annu Rev Immunol"},{"issue":"50","key":"939_CR35","doi-asserted-by":"crossref","first-page":"34583","DOI":"10.1074\/jbc.M114.587675","volume":"289","author":"KM Sand","year":"2014","unstructured":"Sand KM, Bern M, Nilsen J, Dalhus B, Gunnarsen KS, Cameron J, et al. Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn). J Biol Chem. 2014;289(50):34583\u201394.","journal-title":"J Biol Chem"},{"issue":"4","key":"939_CR36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/prot.24230","volume":"81","author":"VZ Spassov","year":"2013","unstructured":"Spassov VZ, Yan L. pH-selective mutagenesis of protein-protein interfaces: in silico design of therapeutic antibodies with prolonged half-life. Proteins. 2013;81(4):704\u201314.","journal-title":"Proteins"},{"issue":"1","key":"939_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/imr.12364","volume":"268","author":"J Cervenak","year":"2015","unstructured":"Cervenak J, Kurrle R, Kacskovics I. Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity. Immunol Rev. 2015;268(1):269\u201387.","journal-title":"Immunol Rev"},{"key":"939_CR38","doi-asserted-by":"crossref","unstructured":"Baker K, Rath T, Pyzik M, Blumberg RS. The role of FcRn in antigen presentation. Front Immunol. 2014;5.","DOI":"10.3389\/fimmu.2014.00408"},{"key":"939_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2017.04.018","volume":"121","author":"D Balasubbramanian","year":"2017","unstructured":"Balasubbramanian D, Gelston CAL, Mitchell BM, Chatterjee P. Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancy. Pharmacol Res. 2017;121:14\u201321.","journal-title":"Pharmacol Res"},{"issue":"4","key":"939_CR40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.immuni.2015.03.003","volume":"42","author":"M Baratin","year":"2015","unstructured":"Baratin M, Foray C, Demaria O, Habbeddine M, Pollet E, Maurizio J, et al. Homeostatic NF-kappaB signaling in steady-state migratory dendritic cells regulates immune homeostasis and tolerance. Immunity. 2015;42(4):627\u201339.","journal-title":"Immunity"},{"issue":"1","key":"939_CR41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","volume":"8","author":"M Mann","year":"2017","unstructured":"Mann M, Mehta A, Zhao JL, Lee K, Marinov GK, Garcia-Flores Y, et al. An NF-kappaB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun. 2017;8(1):851.","journal-title":"Nat Commun"},{"issue":"7782","key":"939_CR42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-019-1612-6","volume":"575","author":"O Majer","year":"2019","unstructured":"Majer O, Liu B, Kreuk LSM, Krogan N, Barton GM. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575(7782):366\u201370.","journal-title":"Nature"},{"issue":"1","key":"939_CR43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-019-08950-3","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Deng Z, Wu H, Zhao Q, Li T, Zhu W, et al. A small secreted protein triggers a TLR2\/4-dependent inflammatory response during invasive Candida albicans infection. Nat Commun. 2019;10(1):1015.","journal-title":"Nat Commun"},{"issue":"1","key":"939_CR44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08830185.2017.1380200","volume":"37","author":"MK Vidya","year":"2018","unstructured":"Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G, Bhatta R. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol. 2018;37(1):20\u201336.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"939_CR45","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/s41467-019-10354-2","volume":"10","author":"Y Feng","year":"2019","unstructured":"Feng Y, Mu R, Wang Z, Xing P, Zhang J, Dong L, et al. A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages. Nat Commun. 2019;10(1):2272.","journal-title":"Nat Commun"},{"issue":"12","key":"939_CR46","volume":"7","author":"C Yin","year":"2016","unstructured":"Yin C, Kim Y, Argintaru D, Heit B. Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis. Cell Death Dis. 2016;7(12):e2529.","journal-title":"Cell Death Dis"},{"issue":"6","key":"939_CR47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3843","volume":"35","author":"ZH Chen","year":"2017","unstructured":"Chen ZH, Yu YP, Zuo ZH, Nelson JB, Michalopoulos GK, Monga S, et al. Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene. Nat Biotechnol. 2017;35(6):543\u201350.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"939_CR48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nri3754","volume":"14","author":"T Kambayashi","year":"2014","unstructured":"Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol. 2014;14(11):719\u201330.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"939_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.it.2005.11.001","volume":"27","author":"SR Burrows","year":"2006","unstructured":"Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol. 2006;27(1):11\u20136.","journal-title":"Trends Immunol"},{"issue":"4","key":"939_CR50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203\u201316.","journal-title":"Nat Rev Immunol"},{"key":"939_CR51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013;31:443\u201373.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"939_CR52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ki.2014.373","volume":"87","author":"JJ Alexander","year":"2015","unstructured":"Alexander JJ, Chaves LD, Chang A, Jacob A, Ritchie M, Quigg RJ. CD11b is protective in complement-mediated immune complex glomerulonephritis. Kidney Int. 2015;87(5):930\u20139.","journal-title":"Kidney Int"},{"issue":"8","key":"939_CR53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nri1149","volume":"3","author":"EE Sercarz","year":"2003","unstructured":"Sercarz EE, Maverakis E. Mhc-guided processing: binding of large antigen fragments. Nat Rev Immunol. 2003;3(8):621\u20139.","journal-title":"Nat Rev Immunol"},{"key":"939_CR54","doi-asserted-by":"crossref","unstructured":"Rausch MP, Hastings KT: Diverse cellular and organismal functions of the lysosomal thiol reductase GILT. Mol Immunol 2015, 68(2 Pt A):124-128.","DOI":"10.1016\/j.molimm.2015.06.008"},{"issue":"1","key":"939_CR55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00251-014-0810-5","volume":"67","author":"G Nikbakht Brujeni","year":"2015","unstructured":"Nikbakht Brujeni G, Khosravi M. Molecular characterization of chicken class II transactivator gene. Immunogenetics. 2015;67(1):39\u201349.","journal-title":"Immunogenetics"},{"issue":"10","key":"939_CR56","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1074\/jbc.H118.001955","volume":"293","author":"K Oliva","year":"2018","unstructured":"Oliva K, Cavanaugh J, Cobb B. Antibody receptors steal the sweet spotlight. J Biol Chem. 2018;293(10):3490\u20131.","journal-title":"J Biol Chem"},{"issue":"2","key":"939_CR57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/annrheumdis-2013-203717","volume":"74","author":"KV Rupanagudi","year":"2015","unstructured":"Rupanagudi KV, Kulkarni OP, Lichtnekert J, Darisipudi MN, Mulay SR, Schott B, et al. Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. Ann Rheum Dis. 2015;74(2):452\u201363.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"939_CR58","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.4049\/jimmunol.180.5.2876","volume":"180","author":"CM Costantino","year":"2008","unstructured":"Costantino CM, Hang HC, Kent SC, Hafler DA, Ploegh HL. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation. J Immunol. 2008;180(5):2876\u201385.","journal-title":"J Immunol"},{"issue":"7","key":"939_CR59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ni.3196","volume":"16","author":"M Samie","year":"2015","unstructured":"Samie M, Cresswell P. The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways. Nat Immunol. 2015;16(7):729\u201336.","journal-title":"Nat Immunol"},{"issue":"4","key":"939_CR60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccell.2016.09.009","volume":"30","author":"I Marigo","year":"2016","unstructured":"Marigo I, Zilio S, Desantis G, Mlecnik B, Agnellini AH, Ugel S, et al. T cell cancer therapy requires CD40-CD40L activation of tumor necrosis factor and inducible nitric-oxide-synthase-producing dendritic cells. Cancer cell. 2016;30(4):651.","journal-title":"Cancer cell"},{"issue":"10","key":"939_CR61","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ni.3535","volume":"17","author":"Y Ding","year":"2016","unstructured":"Ding Y, Guo Z, Liu Y, Li X, Zhang Q, Xu X, et al. The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation. Nat Immunol. 2016;17(10):1167\u201375.","journal-title":"Nat Immunol"},{"issue":"2","key":"939_CR62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clim.2012.01.015","volume":"143","author":"A Akram","year":"2012","unstructured":"Akram A, Inman RD. Immunodominance: a pivotal principle in host response to viral infections. Clin Immunol. 2012;143(2):99\u2013115.","journal-title":"Clin Immunol"},{"issue":"3","key":"939_CR63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","volume":"158","author":"P Nair-Gupta","year":"2014","unstructured":"Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, Huang Y, et al. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell. 2014;158(3):506\u201321.","journal-title":"Cell"},{"key":"939_CR64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2014.00092","volume":"5","author":"AM Avalos","year":"2014","unstructured":"Avalos AM, Ploegh HL. Early BCR events and antigen capture, processing, and loading on MHC class II on B cells. Front Immunol. 2014;5:92.","journal-title":"Front Immunol"},{"key":"939_CR65","first-page":"6338","volume":"356","author":"E Cai","year":"2017","unstructured":"Cai E, Marchuk K, Beemiller P, Beppler C, Rubashkin MG, Weaver VM, et al. Visualizing dynamic microvillar search and stabilization during ligand detection by T cells. Science. 2017;356:6338.","journal-title":"Science"},{"issue":"4","key":"939_CR66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/cr.2017.42","volume":"27","author":"X Guo","year":"2017","unstructured":"Guo X, Yan C, Li H, Huang W, Shi X, Huang M, et al. Lipid-dependent conformational dynamics underlie the functional versatility of T-cell receptor. Cell Res. 2017;27(4):505\u201325.","journal-title":"Cell Res"},{"key":"939_CR67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-032414-112334","volume":"33","author":"J Rossjohn","year":"2015","unstructured":"Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. T cell antigen receptor recognition of antigen-presenting molecules. Annu Rev Immunol. 2015;33:169\u2013200.","journal-title":"Annu Rev Immunol"},{"key":"939_CR68","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/ncomms14754","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Ravindranathan R, Kalinski P, Guo ZS, Bartlett DL. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754.","journal-title":"Nat Commun"},{"key":"939_CR69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-immunol-032414-112014","volume":"34","author":"VR Buchholz","year":"2016","unstructured":"Buchholz VR, Schumacher TN, Busch DH. T cell date at the single-cell level. Annu Rev Immunol. 2016;34:65\u201392.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"939_CR70","doi-asserted-by":"crossref","first-page":"a005140","DOI":"10.1101\/cshperspect.a005140","volume":"2","author":"KW Wucherpfennig","year":"2010","unstructured":"Wucherpfennig KW, Gagnon E, Call MJ, Huseby ES, Call ME. Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling. Cold Spring Harb Perspect Biol. 2010;2(4):a005140.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"939_CR71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2009.00835.x","volume":"232","author":"VP Dave","year":"2009","unstructured":"Dave VP. Hierarchical role of CD3 chains in thymocyte development. Immunol Rev. 2009;232(1):22\u201333.","journal-title":"Immunol Rev"},{"issue":"19","key":"939_CR72","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1039\/C6LC00702C","volume":"16","author":"P Moura Rosa","year":"2016","unstructured":"Moura Rosa P, Gopalakrishnan N, Ibrahim H, Haug M, Halaas O. The intercell dynamics of T cells and dendritic cells in a lymph node-on-a-chip flow device. Lab Chip. 2016;16(19):3728\u201340.","journal-title":"Lab Chip"},{"issue":"1","key":"939_CR73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","volume":"10","author":"X Liu","year":"2017","unstructured":"Liu X, Kwon H, Li Z, Fu YX. Is CD47 an innate immune checkpoint for tumor evasion? J Hematol Oncol. 2017;10(1):12.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"939_CR74","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","volume":"162","author":"S Eickhoff","year":"2015","unstructured":"Eickhoff S, Brewitz A, Gerner MY, Klauschen F, Komander K, Hemmi H, et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell. 2015;162(6):1322\u201337.","journal-title":"Cell"},{"issue":"8","key":"939_CR75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1134\/S0006297915080015","volume":"80","author":"FY Garib","year":"2015","unstructured":"Garib FY, Rizopulu AP. T-regulatory cells as part of strategy of immune evasion by pathogens. Biochemistry (Mosc). 2015;80(8):957\u201371.","journal-title":"Biochemistry (Mosc)"},{"issue":"20","key":"939_CR76","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.15252\/embj.201696003","volume":"36","author":"M Tkach","year":"2017","unstructured":"Tkach M, Kowal J, Zucchetti AE, Enserink L, Jouve M, Lankar D, et al. Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes. EMBO J. 2017;36(20):3012\u201328.","journal-title":"EMBO J"},{"issue":"4","key":"939_CR77","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Andre F, Amigorena S, Soria JC, Eggermont A, Kroemer G, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224\u201332.","journal-title":"J Clin Invest"},{"key":"939_CR78","doi-asserted-by":"crossref","first-page":"42996","DOI":"10.1038\/srep42996","volume":"7","author":"G Wei","year":"2017","unstructured":"Wei G, Jie Y, Haibo L, Chaoneng W, Dong H, Jianbing Z, et al. Dendritic cells derived exosomes migration to spleen and induction of inflammation are regulated by CCR7. Sci Rep. 2017;7:42996.","journal-title":"Sci Rep"},{"issue":"2","key":"939_CR79","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.28549","volume":"64","author":"Q Rao","year":"2016","unstructured":"Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, et al. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2016;64(2):456\u201372.","journal-title":"Hepatology"},{"issue":"4","key":"939_CR80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jhep.2017.05.019","volume":"67","author":"Z Lu","year":"2017","unstructured":"Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739\u201348.","journal-title":"J Hepatol"},{"key":"939_CR81","first-page":"8","volume":"8","author":"JH Lai","year":"2019","unstructured":"Lai JH, Luo SF, Ho LJ. Targeting the CD40-CD154 signaling pathway for treatment of autoimmune arthritis. Cells. 2019;8:8.","journal-title":"Cells"},{"issue":"7689","key":"939_CR82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nature25442","volume":"553","author":"G Pasqual","year":"2018","unstructured":"Pasqual G, Chudnovskiy A, Tas JMJ, Agudelo M, Schweitzer LD, Cui A, et al. Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling. Nature. 2018;553(7689):496\u2013500.","journal-title":"Nature"},{"issue":"2","key":"939_CR83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315\u201327.","journal-title":"Circ Res"},{"issue":"12","key":"939_CR84","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","volume":"122","author":"H Winkels","year":"2018","unstructured":"Winkels H, Ehinger E, Vassallo M, Buscher K, Dinh HQ, Kobiyama K, et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ Res. 2018;122(12):1675\u201388.","journal-title":"Circ Res"},{"key":"939_CR85","doi-asserted-by":"crossref","unstructured":"Gu Y, Liu Y, Fu L, Zhai L, Zhu J, Han Y, et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat Med. 2019.","DOI":"10.1038\/s41591-018-0309-y"},{"issue":"2","key":"939_CR86","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","volume":"25","author":"Y Gu","year":"2019","unstructured":"Gu Y, Liu Y, Fu L, Zhai L, Zhu J, Han Y, et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat Med. 2019;25(2):312\u201322.","journal-title":"Nat Med"},{"key":"939_CR87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","volume":"35","author":"S Bournazos","year":"2017","unstructured":"Bournazos S, Wang T, Dahan R, Maamary J, Ravetch J. Signaling by antibodies: recent progress. Annu Rev Immunol. 2017;35:285\u2013311.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"939_CR88","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/gutjnl-2014-307980","volume":"64","author":"W Wu","year":"2015","unstructured":"Wu W, He C, Liu C, Cao AT, Xue X, Evans-Marin HL, et al. miR-10a inhibits dendritic cell activation and Th1\/Th17 cell immune responses in IBD. Gut. 2015;64(11):1755\u201364.","journal-title":"Gut"},{"issue":"7701","key":"939_CR89","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556(7701):332\u20138.","journal-title":"Nature"},{"issue":"1","key":"939_CR90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3294","volume":"17","author":"TY Halim","year":"2016","unstructured":"Halim TY, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 2016;17(1):57\u201364.","journal-title":"Nat Immunol"},{"issue":"2","key":"939_CR91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","volume":"18","author":"J Walker","year":"2018","unstructured":"Walker J, McKenzie A. T2 cell development and function. Nat Rev Immunol. 2018;18(2):121\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"939_CR92","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","volume":"161","author":"DJ DiLillo","year":"2015","unstructured":"DiLillo DJ, Ravetch JV. Differential Fc-receptor engagement drives an anti-tumor vaccinal effect. Cell. 2015;161(5):1035\u201345.","journal-title":"Cell"},{"issue":"2","key":"939_CR93","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.immuni.2016.01.004","volume":"44","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Li J, Zheng W, Zhao G, Zhang H, Wang X, et al. Peripheral lymphoid volume expansion and maintenance are controlled by gut microbiota via RALDH+ dendritic cells. Immunity. 2016;44(2):330\u201342.","journal-title":"Immunity"},{"issue":"6290","key":"939_CR94","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","volume":"352","author":"I Zanoni","year":"2016","unstructured":"Zanoni I, Tan Y, Di Gioia M, Broggi A, Ruan J, Shi J, et al. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science. 2016;352(6290):1232\u20136.","journal-title":"Science"},{"issue":"5","key":"939_CR95","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2014.10.008","volume":"26","author":"L Zitvogel","year":"2014","unstructured":"Zitvogel L, Kroemer G. CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance. Cancer cell. 2014;26(5):591\u20133.","journal-title":"Cancer cell"},{"issue":"2","key":"939_CR96","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, et al. Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer cell. 2016;30(2):324\u201336.","journal-title":"Cancer cell"},{"issue":"6","key":"939_CR97","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ni.3171","volume":"16","author":"BM Weist","year":"2015","unstructured":"Weist BM, Kurd N, Boussier J, Chan SW, Robey EA. Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition. Nat Immunol. 2015;16(6):635\u201341.","journal-title":"Nat Immunol"},{"key":"939_CR98","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40164-018-0098-5","volume":"7","author":"DE Meyers","year":"2018","unstructured":"Meyers DE, Hill WF, Suo A, Jimenez-Zepeda V, Cheng T, Nixon NA. Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report. Exp Hematol Oncol. 2018;7:6.","journal-title":"Exp Hematol Oncol"},{"key":"939_CR99","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1038\/ncomms11273","volume":"7","author":"T Uto","year":"2016","unstructured":"Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273.","journal-title":"Nat Commun"},{"issue":"2","key":"939_CR100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat Rev Immunol. 2016;16(2):102\u201311.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"939_CR101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","volume":"11","author":"M Liu","year":"2018","unstructured":"Liu M, Wang X, Wang L, Ma X, Gong Z, Zhang S, et al. Targeting the IDO1 pathway in cancer: from bench to bedside. J Hematol Oncol. 2018;11(1):100.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"939_CR102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/cmi.2013.1","volume":"10","author":"H Harizi","year":"2013","unstructured":"Harizi H. Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cell Mol Immunol. 2013;10(3):213\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"939_CR103","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.15252\/emmm.201506164","volume":"8","author":"F Mingozzi","year":"2016","unstructured":"Mingozzi F, Spreafico R, Gorletta T, Cigni C, Di Gioia M, Caccia M, et al. Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors. EMBO Mol Med. 2016;8(9):1039\u201351.","journal-title":"EMBO Mol Med"},{"issue":"11","key":"939_CR104","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41564-019-0506-6","volume":"4","author":"M Palomino-Segura","year":"2019","unstructured":"Palomino-Segura M, Perez L, Farsakoglu Y, Virgilio T, Latino I, D'Antuono R, et al. Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1. Nat Microbiol. 2019;4(11):1930\u201340.","journal-title":"Nat Microbiol"},{"issue":"10","key":"939_CR105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20141678","volume":"212","author":"WP Chong","year":"2015","unstructured":"Chong WP, van Panhuys N, Chen J, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al. NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis. J Exp Med. 2015;212(10):1739\u201352.","journal-title":"J Exp Med"},{"issue":"12","key":"939_CR106","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/gutjnl-2012-303261","volume":"62","author":"HW Xin","year":"2013","unstructured":"Xin HW, Ambe CM, Hari DM, Wiegand GW, Miller TC, Chen JQ, et al. Label-retaining liver cancer cells are relatively resistant to sorafenib. Gut. 2013;62(12):1777\u201386.","journal-title":"Gut"},{"issue":"4","key":"939_CR107","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/stem.1061","volume":"30","author":"HW Xin","year":"2012","unstructured":"Xin HW, Hari DM, Mullinax JE, Ambe CM, Koizumi T, Ray S, et al. Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division. Stem Cells. 2012;30(4):591\u20138.","journal-title":"Stem Cells"},{"issue":"9","key":"939_CR108","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jcmm.13118","volume":"21","author":"Y Liu","year":"2017","unstructured":"Liu Y, Yu C, Wu Y, Sun X, Su Q, You C, et al. CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling. J Cell Mol Med. 2017;21(9):1979\u201388.","journal-title":"J Cell Mol Med"},{"issue":"7659","key":"939_CR109","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503.","journal-title":"Nature"},{"issue":"1","key":"939_CR110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/0008-5472.CAN-17-0469","volume":"78","author":"EA Reap","year":"2018","unstructured":"Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, et al. Dendritic cells enhance polyfunctionality of adoptively transferred T cells that target cytomegalovirus in glioblastoma. Cancer Res. 2018;78(1):256\u201364.","journal-title":"Cancer Res"},{"issue":"8","key":"939_CR111","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","volume":"23","author":"KA Batich","year":"2017","unstructured":"Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, et al. Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination. Clin Cancer Res. 2017;23(8):1898\u2013909.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"939_CR112","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/cncr.30696","volume":"123","author":"HJ Khoury","year":"2017","unstructured":"Khoury HJ, Collins RH Jr, Blum W, Stiff PS, Elias L, et al. Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. Cancer. 2017;123(16):3061\u201372.","journal-title":"Cancer"},{"issue":"15","key":"939_CR113","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2017-04-780155","volume":"130","author":"S Anguille","year":"2017","unstructured":"Anguille S, Van de Velde AL, Smits EL, Van Tendeloo VF, Juliusson G, Cools N, et al. Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia. Blood. 2017;130(15):1713\u201321.","journal-title":"Blood"},{"issue":"12","key":"939_CR114","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/1078-0432.CCR-16-1924","volume":"23","author":"L Lowenfeld","year":"2017","unstructured":"Lowenfeld L, Mick R, Datta J, Xu S, Fitzpatrick E, Fisher CS, et al. Dendritic cell vaccination enhances immune responses and induces regression of HER2(pos) DCIS independent of route: results of randomized selection design trial. Clin Cancer Res. 2017;23(12):2961\u201371.","journal-title":"Clin Cancer Res"},{"key":"939_CR115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejca.2016.06.008","volume":"64","author":"M Caballero-Banos","year":"2016","unstructured":"Caballero-Banos M, Benitez-Ribas D, Tabera J, Varea S, Vilana R, Bianchi L, et al. Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients. Eur J Cancer. 2016;64:167\u201374.","journal-title":"Eur J Cancer"},{"issue":"20","key":"939_CR116","doi-asserted-by":"crossref","first-page":"18192","DOI":"10.18632\/oncotarget.4145","volume":"6","author":"M Podrazil","year":"2015","unstructured":"Podrazil M, Horvath R, Becht E, Rozkova D, Bilkova P, Sochorova K, et al. Phase I\/II clinical trial of dendritic-cell based immunotherapy (DCVAC\/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 2015;6(20):18192\u2013205.","journal-title":"Oncotarget"},{"issue":"4","key":"939_CR117","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/1078-0432.CCR-17-2522","volume":"24","author":"J Aerts","year":"2018","unstructured":"Aerts J, de Goeje PL, Cornelissen R, Kaijen-Lambers MEH, Bezemer K, van der Leest CH, et al. Autologous dendritic cells pulsed with allogeneic tumor cell lysate in mesothelioma: from mouse to human. Clin Cancer Res. 2018;24(4):766\u201376.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"939_CR118","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00262-018-2180-6","volume":"67","author":"H Kimura","year":"2018","unstructured":"Kimura H, Matsui Y, Ishikawa A, Nakajima T, Iizasa T. Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer. Cancer Immunol Immunother. 2018;67(8):1231\u20138.","journal-title":"Cancer Immunol Immunother"},{"issue":"16","key":"939_CR119","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/1078-0432.CCR-17-2707","volume":"24","author":"V Subbiah","year":"2018","unstructured":"Subbiah V, Murthy R, Hong DS, Prins RM, Hosing C, Hendricks K, et al. Cytokines produced by dendritic cells administered intratumorally correlate with clinical outcome in patients with diverse cancers. Clin Cancer Res. 2018;24(16):3845\u201356.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"939_CR120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/bjc.2015.430","volume":"113","author":"JH Lee","year":"2015","unstructured":"Lee JH, Lee Y, Lee M, Heo MK, Song JS, Kim KH, et al. A phase I\/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Br J Cancer. 2015;113(12):1666\u201376.","journal-title":"Br J Cancer"},{"issue":"1","key":"939_CR121","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-017-0459-2","volume":"10","author":"S Mehrotra","year":"2017","unstructured":"Mehrotra S, Britten CD, Chin S, Garrett-Mayer E, Cloud CA, Li M, et al. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017;10(1):82.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"939_CR122","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1200\/JCO.2015.63.4121","volume":"34","author":"S Wilgenhof","year":"2016","unstructured":"Wilgenhof S, Corthals J, Heirman C, van Baren N, Lucas S, Kvistborg P, et al. Phase II study of autologous monocyte-derived mRNA electroporated dendritic cells (TriMixDC-MEL) plus ipilimumab in patients with pretreated advanced melanoma. J Clin Oncol. 2016;34(12):1330\u20138.","journal-title":"J Clin Oncol"},{"issue":"16","key":"939_CR123","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1158\/1078-0432.CCR-16-2821","volume":"23","author":"JM Lee","year":"2017","unstructured":"Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, et al. Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8(+) T-cell infiltration. Clin Cancer Res. 2017;23(16):4556\u201368.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"939_CR124","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/cncr.30606","volume":"123","author":"S Miwa","year":"2017","unstructured":"Miwa S, Nishida H, Tanzawa Y, Takeuchi A, Hayashi K, Yamamoto N, et al. Phase 1\/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma. Cancer. 2017;123(9):1576\u201384.","journal-title":"Cancer"},{"issue":"25","key":"939_CR125","doi-asserted-by":"crossref","first-page":"41538","DOI":"10.18632\/oncotarget.14582","volume":"8","author":"SH Jung","year":"2017","unstructured":"Jung SH, Lee HJ, Lee YK, Yang DH, Kim HJ, Rhee JH, et al. A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma. Oncotarget. 2017;8(25):41538\u201348.","journal-title":"Oncotarget"},{"issue":"17","key":"939_CR126","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/1078-0432.CCR-16-3016","volume":"23","author":"LH Butterfield","year":"2017","unstructured":"Butterfield LH, Zhao F, Lee S, Tarhini AA, Margolin KA, White RL, et al. Immune correlates of GM-CSF and melanoma peptide vaccination in a randomized trial for the adjuvant therapy of resected high-risk melanoma (E4697). Clin Cancer Res. 2017;23(17):5034\u201343.","journal-title":"Clin Cancer Res"},{"issue":"5-6","key":"939_CR127","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41417-018-0016-3","volume":"25","author":"D Wang","year":"2018","unstructured":"Wang D, Wang XW, Peng XC, Xiang Y, Song SB, Wang YY, et al. CRISPR\/Cas9 genome editing technology significantly accelerated herpes simplex virus research. Cancer Gene Ther. 2018;25(5-6):93\u2013105.","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"939_CR128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/hum.2017.189","volume":"29","author":"ZJ Wu","year":"2018","unstructured":"Wu ZJ, Tang FR, Ma ZW, Peng XC, Xiang Y, Zhang Y, et al. Oncolytic viruses for tumor precision imaging and radiotherapy. Hum Gene Ther. 2018;29(2):204\u201322.","journal-title":"Hum Gene Ther"},{"issue":"26","key":"939_CR129","doi-asserted-by":"crossref","first-page":"39768","DOI":"10.18632\/oncotarget.9465","volume":"7","author":"W Zhang","year":"2016","unstructured":"Zhang W, Bao L, Yang S, Qian Z, Dong M, Yin L, et al. Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells. Oncotarget. 2016;7(26):39768\u201383.","journal-title":"Oncotarget"},{"issue":"7543","key":"939_CR130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature14320","volume":"519","author":"DA Mitchell","year":"2015","unstructured":"Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 2015;519(7543):366\u20139.","journal-title":"Nature"},{"issue":"7550","key":"939_CR131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature14424","volume":"521","author":"Y Carmi","year":"2015","unstructured":"Carmi Y, Spitzer MH, Linde IL, Burt BM, Prestwood TR, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521(7550):99\u2013104.","journal-title":"Nature"},{"issue":"6236","key":"939_CR132","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","volume":"348","author":"BM Carreno","year":"2015","unstructured":"Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015;348(6236):803\u20138.","journal-title":"Science"},{"key":"939_CR133","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/scitranslmed.aao5931","volume":"10","author":"J Tanyi","year":"2018","unstructured":"Tanyi J, Bobisse S, Ophir E, Tuyaerts S, Roberti A, Genolet R, et al. Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Sci Transl Med. 2018;10:436.","journal-title":"Sci Transl Med"},{"key":"939_CR134","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biomaterials.2015.03.024","volume":"54","author":"C Li","year":"2015","unstructured":"Li C, Liang S, Zhang C, Liu Y, Yang M, Zhang J, et al. Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer. Biomaterials. 2015;54:177\u201387.","journal-title":"Biomaterials"},{"issue":"6","key":"939_CR135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","volume":"19","author":"PF Robbins","year":"2013","unstructured":"Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med. 2013;19(6):747\u201352.","journal-title":"Nat Med"},{"issue":"12","key":"939_CR136","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.4200","volume":"22","author":"KD Moynihan","year":"2016","unstructured":"Moynihan KD, Opel CF, Szeto GL, Tzeng A, Zhu EF, Engreitz JM, et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med. 2016;22(12):1402\u201310.","journal-title":"Nat Med"},{"issue":"19","key":"939_CR137","doi-asserted-by":"crossref","first-page":"E2646","DOI":"10.1073\/pnas.1604268113","volume":"113","author":"JT Sockolosky","year":"2016","unstructured":"Sockolosky JT, Dougan M, Ingram JR, Ho CC, Kauke MJ, Almo SC, et al. Durable antitumor responses to CD47 blockade require adaptive immune stimulation. Proc Natl Acad Sci U S A. 2016;113(19):E2646\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"939_CR138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biomaterials.2017.01.004","volume":"121","author":"E Koh","year":"2017","unstructured":"Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, et al. Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 2017;121:121\u20139.","journal-title":"Biomaterials"},{"issue":"1","key":"939_CR139","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41467-018-08013-z","volume":"10","author":"Y He","year":"2019","unstructured":"He Y, Bouwstra R, Wiersma VR, de Jong M, Jan Lourens H, Fehrmann R, et al. Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis. Nat Commun. 2019;10(1):533.","journal-title":"Nat Commun"},{"issue":"12","key":"939_CR140","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-18-3267","volume":"25","author":"B Kiss","year":"2019","unstructured":"Kiss B, van den Berg NS, Ertsey R, McKenna K, Mach KE, Zhang CA, et al. CD47-targeted near-infrared photoimmunotherapy for human bladder cancer. Clin Cancer Res. 2019;25(12):3561\u201371.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"939_CR141","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/2326-6066.CIR-16-0398","volume":"5","author":"X Zhang","year":"2017","unstructured":"Zhang X, Fan J, Wang S, Li Y, Wang Y, Li S, et al. Targeting CD47 and autophagy elicited enhanced antitumor effects in non-small cell lung cancer. Cancer Immunol Res. 2017;5(5):363\u201375.","journal-title":"Cancer Immunol Res"},{"key":"939_CR142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ctrv.2016.11.007","volume":"52","author":"JS O'Donnell","year":"2017","unstructured":"O'Donnell JS, Long GV, Scolyer RA, Teng MW, Smyth MJ. Resistance to PD1\/PDL1 checkpoint inhibition. Cancer Treat Rev. 2017;52:71\u201381.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"939_CR143","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-017-0552-6","volume":"11","author":"JA Marin-Acevedo","year":"2018","unstructured":"Marin-Acevedo JA, Soyano AE, Dholaria B, Knutson KL, Lou Y. Cancer immunotherapy beyond immune checkpoint inhibitors. J Hematol Oncol. 2018;11(1):8.","journal-title":"J Hematol Oncol"},{"issue":"7670","key":"939_CR144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","volume":"549","author":"R Mezzadra","year":"2017","unstructured":"Mezzadra R, Sun C, Jae L, Gomez-Eerland R, de Vries E, Wu W, et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 2017;549(7670):106\u201310.","journal-title":"Nature"},{"issue":"1","key":"939_CR145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2013.12.004","volume":"25","author":"X Yang","year":"2014","unstructured":"Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y, et al. Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses. Cancer cell. 2014;25(1):37\u201348.","journal-title":"Cancer cell"},{"issue":"6","key":"939_CR146","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe AE, Chikina M, Dadey RE, Yano H, Brunazzi EA, Shayan G, et al. Interferon-gamma crives Treg fragility to promote anti-tumor immunity. Cell. 2017;169(6):1130\u20131141.e1111.","journal-title":"Cell"},{"issue":"5609","key":"939_CR147","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","volume":"299","author":"C Pasare","year":"2003","unstructured":"Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003;299(5609):1033\u20136.","journal-title":"Science"},{"issue":"7669","key":"939_CR148","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature23665","volume":"548","author":"K Yang","year":"2017","unstructured":"Yang K, Blanco D, Neale G, Vogel P, Avila J, Clish C, et al. Homeostatic control of metabolic and functional fitness of T cells by LKB1 signalling. Nature. 2017;548(7669):602\u20136.","journal-title":"Nature"},{"key":"939_CR149","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1038\/ncomms5229","volume":"5","author":"Y Lu","year":"2014","unstructured":"Lu Y, Zhang M, Wang S, Hong B, Wang Z, Li H, et al. p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression. Nat Commun. 2014;5:4229.","journal-title":"Nat Commun"},{"issue":"7560","key":"939_CR150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/523294a","volume":"523","author":"M Merad","year":"2015","unstructured":"Merad M, Salmon H. Cancer: a dendritic-cell brake on antitumour immunity. Nature. 2015;523(7560):294\u20135.","journal-title":"Nature"},{"issue":"7","key":"939_CR151","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161(7):1527\u201338.","journal-title":"Cell"},{"issue":"3","key":"939_CR152","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1744-9987.12831","volume":"23","author":"M Ogasawara","year":"2019","unstructured":"Ogasawara M, Miyashita M, Yamagishi Y, Ota S. Phase I\/II pilot study of Wilms' tumor 1 peptide-pulsed dendritic cell vaccination combined with conventional chemotherapy in patients with head and neck cancer. Ther Apher Dial. 2019;23(3):279\u201388.","journal-title":"Ther Apher Dial"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-020-00939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-020-00939-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-020-00939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:14:15Z","timestamp":1627946055000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-020-00939-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1186\/s13045-020-00939-6","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"18 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest relating to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}